Global study finds stark differences in maternal RSV vaccine uptake
Vaccination against a common respiratory virus during pregnancy lowers the risk of severe disease in babies by 74%, but uptake in many countries remains low, a new review suggests. The report also reveals evidence of lower uptake of the respiratory syncytial virus (RSV) vaccine among some socioeconomic and ethnic groups, those with reduced access to health care and younger mothers.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Protein LMOD1 offers new clues to muscle regeneration
United Kingdom
-
Fruit fly study reveals how neural gates switch on short-term memory
United Kingdom
-
Intranasal sufentanil-ketamine appears safe, effective for pediatric acute pain
United Kingdom
-
Children living with sickle cell can be treated safely using hydroxyurea, 10-year trial finds
United Kingdom
-
HPV vaccination before pregnancy linked to lower risk of preterm birth and other major complications
United Kingdom
-
NHS labs fail to share data vital for diagnosis and care of rare diseases, investigation finds
United Kingdom
-
About 13% of newly qualified nurses and midwives leave hospital work within six years
United Kingdom
-
New guidance outlines how to protect people living with heart disease during heat waves
United Kingdom